Fundamental analysis · SEC EDGAR · TTM through 31/03/2026

Fundamental analysis of Becton Dickinson & Co

BDX · NYSE · Surgical & Medical Instruments & Apparatus

Fundamental quality

DEMANDING

46

out of 100

Breakdown by area

I.GrowthEPS: -10.7% · Revenue: 4.8%
22
II.ProfitabilityNet margin: 5.1% · ROE: 4.7%
49
III.Financial healthNet debt/EBITDA: 3.33x · FCF: 17.3%
68

Source: SEC EDGAR · TTM through 31/03/2026

Reading the numbers

On average over recent years, earnings per share fell 10.7% a year and revenue advanced 4.8% a year.

On profitability, Becton Dickinson & Co shows a net margin of 5.1%, a gross margin of 34.1%, an ROE of 4.7%.

Its financial health shows net debt of 3.33 times its EBITDA and a free cash flow margin of 17.3%.

Adding up growth, profitability and financial strength, the traffic light gives BDX a fundamental quality of 46 out of 100. To also know whether it's cheap or expensive, the price is missing: enter it in the tool and you'll get the valuation verdict (P/E against its sector).

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Is Becton Dickinson & Co cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →
Advertising

Where to buy Becton Dickinson & Co?

Brokers you can use to invest in U.S. and European stocks.

Compare the brokers →